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Abstract
A 34-year-old woman infected with human T cell leukemia virus type-I(HTLV-I) with re-
current thrombocytopenia and various autoantibodies is described. The platelet counts fluctuated
between 1.3 x 10(4)/microliters and 14.8 x 10(4)/microliters without any medical treatment, and
thrombocytopenia improved with a decrease of platelet-associated IgG (PA-IgG). Autoantibodies
such as rheumatoid factor, antinuclear factor, anti-Sm, anti-RNP and anti-SSA antibodies were
also recognized. Marker analysis of peripheral mononuclear cells showed an increase in the pro-
portion of CD 25+ cells, CD 3+ HLA-DR+ cells, CD4+ HLA-DR+ cells and CD8+ HLA-DR+
cells. The recurrent thrombocytopenia and development of various autoantibodies in this HTLV-
I carrier are speculated to be due to the alteration of B cell functions by T cells infected with
HTLV-I.
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